Chinese clinical-stage biopharma Worg closes $152m Series C round

Chinese clinical-stage biopharma Worg closes $152m Series C round

Photo by RephiLe water on Unsplash

30 June, 2023

Edited by: Pramod Mathew

autoimmune biopharmaceutical biotech immunotherapy Worg Pharmaceuticals

Printed by Unregistered user on Wed, 17 Dec 2025 19:03:48 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

2023 is a tough year for biotech IPOs in HK, says Ascendum Capital’s Serena Shao

China's Sichuan Kelun-Biotech looking to raise $208m Hong Kong IPO

Read more from Greater China

Inside China’s ‘Manhattan Project’ to master the tech to build AI chips

CICC to buy two smaller rivals as Beijing strives for industry consolidation